Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Centanafadine SR: Phase IIb started

January 18, 2016 8:00 AM UTC

Neurovance began a double-blind, placebo-controlled, crossover, U.S. Phase IIb trial to evaluate oral centanafadine SR starting at 100 mg twice daily titrated up to 400 mg twice daily in about 60 adul...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article